Document Detail

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings.
MedLine Citation:
PMID:  24747156     Owner:  NLM     Status:  In-Data-Review    
HIV-1 drug resistance has the potential to seriously compromise the effectiveness and impact of antiretroviral therapy (ART). As ART programs in sub-Saharan Africa continue to expand, individuals on ART should be closely monitored for the emergence of drug resistance. Surveillance of transmitted drug resistance to track transmission of viral strains already resistant to ART is also critical. Unfortunately, drug resistance testing is still not readily accessible in resource limited settings, because genotyping is expensive and requires sophisticated laboratory and data management infrastructure. An open access genotypic drug resistance monitoring method to manage individuals and assess transmitted drug resistance is described. The method uses free open source software for the interpretation of drug resistance patterns and the generation of individual patient reports. The genotyping protocol has an amplification rate of greater than 95% for plasma samples with a viral load >1,000 HIV-1 RNA copies/ml. The sensitivity decreases significantly for viral loads <1,000 HIV-1 RNA copies/ml. The method described here was validated against a method of HIV-1 drug resistance testing approved by the United States Food and Drug Administration (FDA), the Viroseq genotyping method. Limitations of the method described here include the fact that it is not automated and that it also failed to amplify the circulating recombinant form CRF02_AG from a validation panel of samples, although it amplified subtypes A and B from the same panel.
Justen Manasa; Siva Danaviah; Sureshnee Pillay; Prevashinee Padayachee; Hloniphile Mthiyane; Charity Mkhize; Richard John Lessells; Christopher Seebregts; Tobias F Rinke de Wit; Johannes Viljoen; David Katzenstein; Tulio De Oliveira
Related Documents :
24576596 - Peptide hydrogels as mucoadhesives for local drug delivery.
23734106 - Episodic memories and their relevance for psychoactive drug use and addiction.
16119636 - Neuroprotection possibilities in epileptic children.
23383426 - Strategies to address low drug solubility in discovery and development.
8710046 - Cytochrome p450 isoenzymes--importance for the internist.
22483936 - Biomarkers of cell death applicable to early clinical trials.
Publication Detail:
Type:  Journal Article     Date:  2014-03-30
Journal Detail:
Title:  Journal of visualized experiments : JoVE     Volume:  -     ISSN:  1940-087X     ISO Abbreviation:  J Vis Exp     Publication Date:  2014  
Date Detail:
Created Date:  2014-04-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101313252     Medline TA:  J Vis Exp     Country:  United States    
Other Details:
Languages:  eng     Pagination:  -     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Does desire for hastened death change in terminally ill cancer patients?
Next Document:  The effects of information type (features vs. configuration) and location (eyes vs. mouth) on the de...